These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 17465207)
1. Functional alteration of myeloid dendritic cells through head and neck cancer. Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207 [TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor interference in myeloid dendritic cells through head and neck cancer. Frenzel H; Hoffmann B; Brocks C; Schlenke P; Pries R; Wollenberg B Anticancer Res; 2006; 26(6B):4409-13. PubMed ID: 17201162 [TBL] [Abstract][Full Text] [Related]
3. Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein. Frenzel H; Pries R; Brocks CP; Jabs WJ; Wittkopf N; Wollenberg B Anticancer Res; 2007; 27(6B):4111-5. PubMed ID: 18225580 [TBL] [Abstract][Full Text] [Related]
4. Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells. Thiel A; Pries R; Jeske S; Trenkle T; Wollenberg B Anticancer Res; 2009 Aug; 29(8):3019-25. PubMed ID: 19661310 [TBL] [Abstract][Full Text] [Related]
5. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840 [TBL] [Abstract][Full Text] [Related]
6. Isolation of human myeloid dendritic cells from tumor tissue and peripheral blood. Brocks C; Graefe H; Frenzel H; Pries R; Wollenberg B In Vivo; 2006; 20(2):239-42. PubMed ID: 16634524 [TBL] [Abstract][Full Text] [Related]
7. Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood. Nitsch SM; Pries R; Wollenberg B In Vivo; 2007; 21(3):493-8. PubMed ID: 17591359 [TBL] [Abstract][Full Text] [Related]
8. Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma. Pries R; Thiel A; Brocks C; Wollenberg B In Vivo; 2006; 20(1):45-8. PubMed ID: 16433027 [TBL] [Abstract][Full Text] [Related]
9. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma. Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728 [TBL] [Abstract][Full Text] [Related]
10. Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck. Kacani L; Wurm M; Schwentner I; Andrle J; Schennach H; Sprinzl GM Oral Oncol; 2005 Jan; 41(1):17-24. PubMed ID: 15598581 [TBL] [Abstract][Full Text] [Related]
11. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593 [TBL] [Abstract][Full Text] [Related]
12. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma. Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944 [TBL] [Abstract][Full Text] [Related]
13. IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro. Egan JE; Quadrini KJ; Santiago-Schwarz F; Hadden JW; Brandwein HJ; Signorelli KL J Immunother; 2007 Sep; 30(6):624-33. PubMed ID: 17667526 [TBL] [Abstract][Full Text] [Related]
14. Increased cytokine secretion in head and neck cancer upon p38 mitogen-activated protein kinase activation. Riebe C; Pries R; Kemkers A; Wollenberg B Int J Mol Med; 2007 Dec; 20(6):883-7. PubMed ID: 17982698 [TBL] [Abstract][Full Text] [Related]
15. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis. Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596 [TBL] [Abstract][Full Text] [Related]
16. Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells. Lathers DM; Achille N; Kolesiak K; Hulett K; Sparano A; Petruzzelli GJ; Young MR Otolaryngol Head Neck Surg; 2001 Sep; 125(3):205-12. PubMed ID: 11555755 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells and HNSCC: a potential treatment option? (Review). Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7. Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362 [TBL] [Abstract][Full Text] [Related]
19. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma. Kato H; Whiteside TL Tokai J Exp Clin Med; 2011 Dec; 36(4):144-51. PubMed ID: 22167499 [TBL] [Abstract][Full Text] [Related]
20. Cytokines in head and neck cancer. Pries R; Wollenberg B Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]